Enliven Therapeutics Inc (NASDAQ: ELVN) Is Up 50.14% From Its 52-Week Low; YTD, It Is Down -2.84% – What To Do Now
During the last session, Enliven Therapeutics Inc (NASDAQ:ELVN)’s traded shares were 0.51 million, with the beta value of the company hitting 1.02. At the end